NCT02582658View on ClinicalTrials.gov

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)

CompletedOBSERVATIONAL
Enrollment

173

Participants

Timeline

Start Date

October 6, 2015

Primary Completion Date

January 12, 2017

Study Completion Date

January 12, 2017

Conditions
Chronic Hepatitis C
Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY